Literature DB >> 27567437

Cocaine self-administration and reinstatement in female rats selectively bred for high and low voluntary running.

J R Smethells1, N E Zlebnik2, D K Miller3, M J Will3, F Booth4, M E Carroll2.   

Abstract

BACKGROUND: Previous research has found that rats behaviorally screened for high (vs. low) wheel running were more vulnerable to cocaine abuse. To assess the extent to which a genetic component is involved in this drug-abuse vulnerability, rats selectively bred for high or low voluntary running (HVR or LVR, respectively) were examined for differences in cocaine seeking in the present study.
METHODS: Female rats were trained to lever press for food and then were assessed for differences in acquisition of cocaine (0.4mg/kg; i.v.) self-administration across 10 sessions. Once acquired, rats self-administered cocaine for a 14-day maintenance phase, followed by a 14-day extinction phase when cocaine was no longer available. Subsequently, reinstatement of cocaine seeking was examined with priming injections of cocaine (5, 10 & 15mg/kg), caffeine (30mg/kg), yohimbine (2.5mg/kg) and cocaine-paired cues.
RESULTS: A greater percentage of LVR rats met the acquisition criteria for cocaine self-administration and in fewer sessions than HVR rats. No differences in responding for cocaine were observed between phenotypes during maintenance. However, during extinction LVR rats initially responded at higher rates and persisted in cocaine seeking for a greater number of sessions. No phenotype differences were observed following drug and cue-primed reinstatement of cocaine seeking.
CONCLUSIONS: In general, LVR rats were more sensitive to the reinforcing effects of cocaine than HVR rats during periods of transition into and out of cocaine self-administration. Thus, LVR rats sometimes showed a greater vulnerability cocaine seeking than HVR rats. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Acquisition; Cocaine self-administration; Extinction; Phenotype; Rats; Wheel running

Mesh:

Substances:

Year:  2016        PMID: 27567437      PMCID: PMC5037047          DOI: 10.1016/j.drugalcdep.2016.08.020

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  38 in total

1.  Long-term voluntary wheel running is rewarding and produces plasticity in the mesolimbic reward pathway.

Authors:  Benjamin N Greenwood; Teresa E Foley; Tony V Le; Paul V Strong; Alice B Loughridge; Heidi E W Day; Monika Fleshner
Journal:  Behav Brain Res       Date:  2010-11-09       Impact factor: 3.332

2.  Access to a running wheel decreases cocaine-primed and cue-induced reinstatement in male and female rats.

Authors:  Mark A Smith; Michael M Pennock; Katherine L Walker; Kimberly C Lang
Journal:  Drug Alcohol Depend       Date:  2011-08-31       Impact factor: 4.492

Review 3.  Neuroscience of addiction.

Authors:  G F Koob; P P Sanna; F E Bloom
Journal:  Neuron       Date:  1998-09       Impact factor: 17.173

4.  DARPP-32: regulator of the efficacy of dopaminergic neurotransmission.

Authors:  A A Fienberg; N Hiroi; P G Mermelstein; W Song; G L Snyder; A Nishi; A Cheramy; J P O'Callaghan; D B Miller; D G Cole; R Corbett; C N Haile; D C Cooper; S P Onn; A A Grace; C C Ouimet; F J White; S E Hyman; D J Surmeier; J Girault; E J Nestler; P Greengard
Journal:  Science       Date:  1998-08-07       Impact factor: 47.728

5.  Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the 'runner's high'.

Authors:  David A Raichlen; Adam D Foster; Gregory L Gerdeman; Alexandre Seillier; Andrea Giuffrida
Journal:  J Exp Biol       Date:  2012-04-15       Impact factor: 3.312

6.  Food deprivation increases oral and intravenous drug intake in rats.

Authors:  M E Carroll; C P France; R A Meisch
Journal:  Science       Date:  1979-07-20       Impact factor: 47.728

7.  Differential sensitivity to acute administration of cocaine, GBR 12909, and fluoxetine in mice selectively bred for hyperactive wheel-running behavior.

Authors:  J S Rhodes; G R Hosack; I Girard; A E Kelley; G S Mitchell; T Garland
Journal:  Psychopharmacology (Berl)       Date:  2001-11       Impact factor: 4.530

8.  Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats.

Authors:  Jennifer L Perry; Erin B Larson; Jonathan P German; Gregory J Madden; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

9.  Techniques for establishing schedules with wheel running as reinforcement in rats.

Authors:  I H Iversen
Journal:  J Exp Anal Behav       Date:  1993-07       Impact factor: 2.468

10.  Impulsive choice as a predictor of acquisition of IV cocaine self- administration and reinstatement of cocaine-seeking behavior in male and female rats.

Authors:  Jennifer L Perry; Sarah E Nelson; Marilyn E Carroll
Journal:  Exp Clin Psychopharmacol       Date:  2008-04       Impact factor: 3.157

View more
  4 in total

Review 1.  Aerobic exercise as a promising nonpharmacological therapy for the treatment of substance use disorders.

Authors:  Gigliola Marrero-Cristobal; Ursula Gelpi-Dominguez; Roberto Morales-Silva; John Alvarado-Torres; Joshua Perez-Torres; Yobet Perez-Perez; Marian Sepulveda-Orengo
Journal:  J Neurosci Res       Date:  2021-12-01       Impact factor: 4.433

2.  Effects of voluntary exercise and sex on multiply-triggered heroin reinstatement in male and female rats.

Authors:  J R Smethells; A Greer; B Dougen; M E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2019-11-11       Impact factor: 4.530

3.  (±)VK4-40, a novel dopamine D3 receptor partial agonist, attenuates cocaine reward and relapse in rodents.

Authors:  Chloe J Jordan; Yi He; Guo-Hua Bi; Zhi-Bing You; Jianjing Cao; Zheng-Xiong Xi; Amy Hauck Newman
Journal:  Br J Pharmacol       Date:  2020-09-17       Impact factor: 9.473

4.  A Multilevel Computational Characterization of Endophenotypes in Addiction.

Authors:  Vincenzo G Fiore; Dimitri Ognibene; Bryon Adinoff; Xiaosi Gu
Journal:  eNeuro       Date:  2018-07-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.